|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2022
12 months to Dec 31, 2022
|
FY2021
8 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Net income (loss) | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Amortization of debt discount | ||||
| Shares issued for services | ||||
| Shares issued for forbearance fee | ||||
| Default penalties and interest on notes payable | ||||
| Change in fair value of warrant liability | ||||
| Interest expense - debt discount | ||||
| Change in fair value of earnout shares liability | ||||
| Stock issued for forbearance fee | ||||
| Change in assets and liabilities: | ||||
| Royalty receivable | ||||
| Other receivable | ||||
| Prepaid expenses | ||||
| Other receivables | ||||
| Employee advance | ||||
| Accounts payable and accrued expenses | ||||
| Accrued expenses - related party | ||||
| Accrued interest payable - related party | ||||
| Net cash used in operating activities | ||||
| Purchase of property, plant and equipment | ||||
| Cash acquired with merger | ||||
| Acquisition costs | ||||
| Net cash provided by investing activities | ||||
| Proceeds from notes payable to related party | ||||
| Repayment of due to investor | ||||
| Proceeds from convertible notes payable | ||||
| Repayment of convertible notes payable | ||||
| Proceeds from financing payable | ||||
| Repayment of financing payable | ||||
| Proceeds from sale of common stock | ||||
| Net cash provided by financing activities | ||||
| Cash and restricted cash – beginning of the year | ||||
| Cash and restricted cash – end of the year | ||||
| Net change in cash | ||||
| Cash at beginning of period | ||||
| Cash at end of period | ||||
| Supplemental disclosures of cash flow information: | ||||
| Cash paid for taxes | ||||
| Supplemental non-cash investing and financing information | ||||
| Common shares issued as financing incentive | ||||
| Common shares issued from conversion of preferred series C shares | ||||
| Common shares issued from conversion of convertible notes payable | ||||
| Warrants issued with convertible notes payable | ||||
| Reversal of excise tax liability | ||||
| Net assets and liabilities assumed in the merger | ||||
| Common shares cancelled per forfeiture agreement | ||||
| Common shares issued for note extension with related party | ||||
| Shares issued to related party applied directly against accumulated deficit | ||||
| Discounts on notes payable applied directly against accumulated deficit | ||||
Loading...